• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    Aspire Biopharma, Interwest to Accelerate Buzz Bomb Retail

    PHARMIWEB

    Aspire Bio Subsidiary Partners With Trulife For National Retail

    PHARMIWEB

    Aspire Bio`s BUZZ BOMB(TM) Shakes Up Energy Market

    PHARMIWEB

    Aspire Bio Subsidiary To Present BUZZ BOMB(TM) Caffeine

    PHARMIWEB

    Aspire Bio Welcomes Ashley Paulson As Global Brand Ambassador

    PHARMIWEB

    Aspire Bio Granted Extension By Nasdaq Hearing Panel

    PHARMIWEB

    Aspire Biopharma Provides Q3 2025 Business Update

    PHARMIWEB

    Aspire Bio Engages Global Pharma Leaders At CPHI Frankfurt

    PHARMIWEB

    Aspire Bio Engages Athletes, Influencers to Boost BUZZ BOMB(TM)

    PHARMAWEB

    Aspire Biopharma Unveils Final Results of Sublingual Aspirin

    ACCESSWIRE

    Aspire Biopharma Reports Positive Results in Trial of Sublingual

    ACCESSWIRE

    Aspire Launches BUZZ BOMB(TM) Supplement at FitCon and FitExpo

    PHARMAWEB

    Aspire Bio to Launch BUZZ BOMB Supplement at FitCon & FitExpo

    ACCESSWIRE

    Aspire Biopharma Holdings Names Michael C. Howe New CEO

    ACCESSWIRE

    Aspire Biopharma Updates on BUZZ BOMB(TM) Launch in Q3 2025

    ACCESSWIRE

    Aspire Biopharma starts Phase 1 trial for high-dose Aspirin

    ACCESSWIRE

    Aspire Biopharma to Present at Sidoti Virtual Investor Conference

    ACCESSWIRE

    Aspire Biopharma to Present at Emerging Growth Conference on April

    ACCESSWIRE

    Aspire Biopharma begins producing pre-workout Supplement

    ACCESSWIRE

    Aspire Biopharma Provides an Update on Lead Product Candidate

    ACCESSWIRE

    Aspire Biopharma Holdings Announce Public Listing on Nasdaq

    ACCESSWIRE

    Aspire Biopharma Signs Securities Purchase Agreement

    ACCESSWIRE

    Aspire Biopharma Announces Public Listing on Nasdaq

    ACCESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.